Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New artificial disc could replace fusion for neck pain

NCT ID NCT02667067

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new artificial disc called Simplify® for people with severe neck and arm pain from cervical degenerative disc disease. The trial involved 150 adults who received the disc and were compared to a historical group that had spinal fusion surgery. The goal was to see if the artificial disc is as safe and effective as fusion, while allowing more natural neck movement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Simplify® cervical artificial disc (a medical device)
What this could lead to
If successful, this artificial disc could offer a motion-preserving alternative to spinal fusion for people with severe neck and arm pain.
What could go wrong
This is a completed trial comparing a device to an older surgery. Results may not apply to all patients, and device-related risks like failure or need for additional surgery remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Nov 2015

Finished

Jul 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be between 18 and 60 years of age; * Have symptoms of cervical degenerative disc disease (DDD) at one cervical level from C3 to C7 defined as intractable radiculopathy (arm pain and /or a neurological deficit) with or without neck pain or myelopathy due to a single-level abnormality localized to the level of the disc space and radiographic evidence of at least one of the following; 1. Spondylosis (defined by the presence of osteophytes or dark disc) on CT or MRI or; 2. Disc height decreased by ≥ 1 mm when compared to adjacent levels on radiographic film, CT, or MRI or 3. Disc herniation on CT or MRI; * Have at least one of the following radiculopathy or myelopathy symptoms in neck and/or arm; 1. Pain or paresthesias in a specific nerve root distribution from C3 to C7, 2. Decreased muscle strength of at least one level on the 0-5 scale, or 3. Abnormal sensation, including hyperesthesia or hypoesthesia. * Have at least one of the following: 1. At least six weeks of prior conservative treatment (e.g., physical therapy and/or use of anti-inflammatory medications and muscle relaxants at the manufacturer's recommended therapeutic dose); 2. The presence of progressive symptoms (e.g., increasing numbness or tingling) or 3. Signs of nerve root compression. * Have a Neck Disability Index (NDI) greater than or equal to 40 on a scale of 100 (moderate disability); * Be appropriate for treatment using an anterior surgical approach; * Be likely to return for all follow-up visits and * Be willing and able to provide Informed Consent for study participation. Exclusion Criteria: * Marked cervical instability on resting lateral or flexion/ extension X-ray (translation \> 3 mm or \> 11 degrees rotation to that of either adjacent non-treatment level); * Non discogenic neck pain or non discogenic source of symptoms (e.g., tumor, rotator cuff injury, etc.); * Radiographic confirmation of severe facet disease or facet degeneration; * Bridging osteophytes; * Less than 2 degrees of motion at index level; * Prior surgery at the level to be treated, except laminotomy without accompanying facetectomy; * Prior fusion at any cervical level; * More than one neck surgery via anterior approach; * Previous trauma to the C3-C7 levels resulting in compression or bursting; * Documented presence of a free nuclear fragment at cervical levels other than the study level; * Axial neck pain only (no radicular or myelopathy symptoms); * Symptomatic DDD at more than one cervical level; * Severe myelopathy (less than 3/5 muscle strength); * Any paralysis; * Recent history (within previous six months) of chemical or alcohol dependence; * Active systemic infection; * Infection at the site of surgery; * Prior disc space infection or osteomyelitis in the cervical spine; * Any terminal, systemic or autoimmune disease; * Metabolic bone disease (e.g., osteoporosis/osteopenia , gout, osteomalacia, Paget's disease); * Any disease, condition or surgery which might impair healing, such as; 1. Diabetes mellitus requiring daily insulin management, 2. Active malignancy, 3. History of metastatic malignancy. * Current or extended use (\> 6 months) of any drug known to interfere with bone or soft tissue healing; * Known PEEK, ceramic, titanium allergy; * Arachnoiditis; * Significant cervical anatomical deformity at the index level or clinically compromised cervical vertebral bodies at the index level due to current or past trauma (e.g., by radiographic appearance of fracture callus, malunion, or nonunion) or disease (e.g., ankylosing spondylitis, rheumatoid arthritis); * Currently experiencing an episode of major mental illness (psychosis, major affective disorder, or schizophrenia), or manifesting physical symptoms without a diagnosable medical condition to account for the symptoms, which may indicate symptoms of psychological rather than physical origin; * Pregnancy at time of enrollment, or planning to become pregnant, since this would contraindicate surgery ; * Use of spinal stimulator at any cervical level prior to surgery; * Currently a prisoner; * Currently involved in spinal litigation which may influence the subjects reporting of symptoms or * Participation in any other investigational drug, biologic or medical device study within the last 30 days prior to study surgery.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical degenerative disc disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Study site

    La Jolla, California, United States

  • Study site

    Orange, California, United States

  • Study site

    Santa Monica, California, United States

  • Study site

    Thornton, Colorado, United States

  • Study site

    Sarasota, Florida, United States

  • Study site

    Evanston, Illinois, United States

  • Study site

    Carmel, Indiana, United States

  • Study site

    Paducah, Kentucky, United States

  • Study site

    Shreveport, Louisiana, United States

  • Study site

    Egg Harbor, New Jersey, United States

  • Study site

    Lockport, New York, United States

  • Study site

    Charlotte, North Carolina, United States

  • Study site

    Addison, Texas, United States

  • Study site

    Plano, Texas, United States

  • Study site

    Tyler, Texas, United States

  • Study site

    Reston, Virginia, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.